Luminex Corporation | Biotechnology Company
Customer Center
Login | Register


Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More

Luminex® Blog

Luminex Licensed Technologies Partner Spotlight: Radix BioSolutions

Custom assay development

At Radix, scientists design and manufacture Luminex assays so their customers can focus on what they’re really interested in: the results. The company is one of our Licensed Technologies Partners, a group that includes a wide range of markets, organization types, and locations. All of the Licensed Technologies Partners conduct work that is powered by Luminex’s versatile xMAP® Technology, which has supported the launch of thousands of multiplexed immunoassays as the basis for commercially available kits and testing services.‬‬

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

Considering a career in manufacturing? Get the inside scoop from Terry Knighton, Director of Instrument Manufacturi…
h J R
RT @DrNancyM_CDC: There is NO current multi-state #measles outbreak in the US. Some recent media reports misinterpreted data regularly issu…
h J R
As we gear up for #xMAPConnect, a #TBT to this great presentation from Hans-Dieter Zucht of #Protagen from last yea…
h J R

Latest News

August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results

July 13
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018

June 13
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay

May 18
Luminex Corporation to Present at Upcoming Healthcare Investor Conferences

May 18
Luminex Corporation Declares Second Quarter Cash Dividend


2-5 September
Amsterdam, Netherlands

Microbe UK
21-23 September
Sheffield, UK

World Vaccine Congress
29-31 October
Lisbon, Portugal

xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands